跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,604 条关于
“PPAR α,δ”
全部
1,604
临床试验
646
药物
508
机构
9
资讯
441
2年前
U.S. FDA Grants Priority Review for Elafibranor, a Potential New Treatment for Primary Biliary Cholangitis
去年
Elafibranor Shows No Impact on Renal Function in Primary Biliary Cholangitis Patients
去年
Elafibranor Demonstrates Improved Transplant-Free Survival in PBC Patients
2年前
Elafibranor Shows Significant Efficacy in Phase III Trial for Primary Biliary Cholangitis
10个月前
IQIRVO Shows Sustained Long-Term Benefits in Primary Biliary Cholangitis with Novel Fatigue Mechanism Insights
去年
Lanifibranor Phase 1 Trial Launches in Japan for MASH Treatment Development
去年
Primary Biliary Cholangitis Pipeline Shows Strong Progress with Multiple Late-Stage Therapies and Recent FDA Approvals
21天前
Self-Assembled α-Helical Peptide Nanopores Enable Ultrasensitive, Charge-Selective Detection of Parkinson's α-Synuclein Variants
去年
New PPAR Agonists Expand Treatment Landscape for Primary Biliary Cholangitis
去年
PPAR-gamma Pathway Modulation Enhances NECTIN4-Targeted CAR-T Therapy for Bladder Cancer
第 1 页,共 45 页
上一页
下一页